Literature DB >> 3310685

Cross-reactivity among different Giardia lamblia isolates using immunofluorescent antibody and enzyme immunoassay techniques.

B L Ungar1, T E Nash.   

Abstract

Rabbit antisera to 11 Giardia lamblia isolates were reacted with 8 G. lamblia isolates using single antibody ELISA and indirect immunofluorescent antibody techniques (IFA). Using living trophozoite organisms, IFA showed marked surface fluorescence with homologous antisera-organism pairs while heterologous pairs showed reduced or no reactivity. Using formalin-fixed trophozoites, the pattern of fluorescence changed to include diffuse internal fluorescence with both homologous and heterologous pairs. In contrast to the variability in surface fluorescence, similar reactivity was noted for homologous and heterologous antisera-isolate pairs with the ELISA. In addition, a double antibody enzyme immunoassay using rabbit antisera prepared to 2 G. lamblia isolates was performed with 8 different isolates as test antigen. All 8 were equally well detected. These data confirm previous findings that G. lamblia isolates have both different and common antigens. The different antigens appear to be on the surface of the organism while the common antigens appear to be internal or somatic.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3310685     DOI: 10.4269/ajtmh.1987.37.283

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  vsp gene expression by Giardia lamblia clone GS/M-83-H7 during antigenic variation in vivo and in vitro.

Authors:  M Bienz; M Siles-Lucas; P Wittwer; N Müller
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  In vitro synthesized immunoglobulin A from nu/+ and reconstituted nu/nu mice against a dominant surface antigen of Giardia lamblia.

Authors:  B Gottstein; P Deplazes; I Tanner
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

3.  Antigenic variation of Giardia lamblia in vivo.

Authors:  A Aggarwal; T E Nash
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.